Molecular pathology of lymphoma
Author:
- 7 December 2012
- journal article
- review article
- Published by Springer Nature in Eye
- Vol. 27 (2) , 180-189
Abstract
Ocular lymphomas can be divided into intraocular lymphomas and ocular adnexal lymphomas. The vitreoretinal lymphoma—usually a diffuse large B-cell lymphoma (DLBCL) of high-grade malignancy—is the most common lymphoid malignancy arising in the eye, while the extranodal marginal zone B-cell lymphoma (EMZL), an indolent often recurrent tumour, occurs most frequently in the ocular adnexal tissue. The two lymphoma subtypes differ significantly in their clinical presentation, subsequent course and outcome as well as in their underlying morphological, immunophenotypical and genetic features. The molecular processes involved in DLBCL and EMZL development are complex, and include chromosomal translocations, mutations caused by aberrant somatic hypermutation, sporadic somatic mutations, and copy number alterations, characterized by deletions and amplifications. These lead to alterations in particular signalling pathways, which in turn activate transcription factors, such as nuclear factor NF-κB. This review provides an overview of the histological features of DLBCL and EMZL, and discusses the current insights into the molecular mechanisms underlying the development of these tumours, when they occur systemically and particularly when they arise in ocular tissues.Keywords
This publication has 80 references indexed in Scilit:
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applicationsBlood, 2011
- Treatment of isolated primary intraocular lymphoma with high‐dose methotrexate‐based chemotherapy and binocular radiation therapy: a single‐institution experienceBritish Journal of Haematology, 2010
- Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cellsBlood, 2010
- Extranodal marginal zone lymphoma of the ocular adnexaBlood, 2009
- BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphomaProceedings of the National Academy of Sciences, 2009
- Use of similar immunoglobulin VH gene segments by MALT lymphomas of the ocular adnexaLaboratory Investigation, 2009
- The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCLBlood, 2009
- Cytofluorographic and molecular identification of a CD8-positive, TCR-α/β-negative intraocular T cell lymphoma: a case report and review of the literatureJournal of Medical Case Reports, 2007
- Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell–like diffuse large B cell lymphomaJournal of Experimental Medicine, 2007
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000